Amgen Inc (AMGN)
294.30
+4.40
(+1.52%)
USD |
NASDAQ |
Nov 22, 14:08
Amgen Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 6.36B |
December 31, 2021 | 1.443B |
September 30, 2021 | 1.08B |
June 30, 2021 | 1.581B |
March 31, 2021 | 871.00M |
December 31, 2020 | 1.205B |
September 30, 2020 | 765.00M |
June 30, 2020 | 555.00M |
March 31, 2020 | 961.00M |
December 31, 2019 | 1.094B |
September 30, 2019 | 1.161B |
June 30, 2019 | 2.415B |
March 31, 2019 | 3.032B |
December 31, 2018 | 2.124B |
September 30, 2018 | 1.729B |
June 30, 2018 | 3.244B |
March 31, 2018 | 10.70B |
December 31, 2017 | 789.00M |
September 30, 2017 | 809.00M |
June 30, 2017 | 976.00M |
March 31, 2017 | 586.00M |
December 31, 2016 | 983.00M |
Date | Value |
---|---|
September 30, 2016 | 764.00M |
June 30, 2016 | 542.00M |
March 31, 2016 | 676.00M |
December 31, 2015 | 183.00M |
September 30, 2015 | 744.00M |
June 30, 2015 | 476.00M |
March 31, 2015 | 464.00M |
December 31, 2014 | 138.00M |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 832.00M |
December 31, 2012 | 1.217B |
September 30, 2012 | 810.00M |
June 30, 2012 | 1.205B |
March 31, 2012 | 1.375B |
December 31, 2011 | 5.424B |
September 30, 2011 | 2.259B |
June 30, 2011 | 634.00M |
March 31, 2011 | -2.00M |
December 31, 2010 | 1.192B |
September 30, 2010 | 294.00M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2022
6.36B
Maximum
Mar 2022
1.224B
Average
961.00M
Median
Mar 2020
Stock Buybacks (Quarterly) Benchmarks
Johnson & Johnson | 539.00M |
Eli Lilly and Co | 446.10M |
Merck & Co Inc | 444.00M |
Regeneron Pharmaceuticals Inc | 600.60M |
Viking Therapeutics Inc | -46.66M |